novo nordisk glp-1 patent litigation A/S (NVO) Securities Class Action Lawsuit Update Novo Nordisk is suing Eli

Overall, these results may be used for preliminary MNT guidance for this population, and the researchers call for future large-scale studies to confirm these findings and develop more specific nutritional protocols that account for the unique needs of GLP-1RA users

Potential Side Effects While there are no large randomized controlled studies, some common side effects reported include injection-site reactions (pain, erythema, swelling), headache, nausea, diarrhea, and rare hypersensitivity reactions

You have to be patient to see the changes

Storage & handling Store the lyophilized vial refrigerated at 28C, protected from light and heat Reconstitute with bacteriostatic water

References Sanchez-Garrido, M

For most users, evening administration provides the best balance of effectiveness and convenience